Point‐of‐Care Ultrasound (<scp>POCUS</scp>) for Precision Management in Ellanse‐Treated Patients
Our limited case series of 6 patients provides useful insights into the effectiveness of POCUS as the initial imaging modality of choice when managing Ellanse-treated patients. POCUS imaging provides valuable diagnostic information (Patient A, B, C and D) and therapeutic purposes such as POCUS guided injection and pretreatment assessment (Patient D and E). POCUS can be the initial imaging modality of choice as it is convenient and allows clinical management to be made based on imaging findings.
Authors
- Larry Wu (ORCID: https://orcid.org/0000-0002-8020-3021)
- Franco Vercesi (ORCID: https://orcid.org/0000-0001-9011-1684)
- Giovanni Salti (ORCID: https://orcid.org/0000-0002-7336-154X)
- Sebastian Cotofana (ORCID: https://orcid.org/0000-0001-7210-6566)
Institutions
- nLIGHT (United States) (US)
- Queen Mary University of London (GB)
- University of Milan (IT)
- Institute of Medical Biology (SG)
- Guangdong Provincial People's Hospital (CN)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1111/jocd.70262
- Citations
- 1
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.00